Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04749615 · ClinicalTrials.gov registry record · Phase 4
Does PAI Reduce Pain After TKA Among Knee Arthroplasty Patients Receiving ACB & IPACK?
A Phase 4 study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 94
- Enrollment target
NCT04749615 is a Phase 4 study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 94 participants.
The verdict
NCT04749615, a Phase 4 study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 94 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to determine whether Periarticular Injection (PAI) alongside Adductor Canal Block (ACB) and Infiltration between the Popliteal Artery and Capsule of the Knee (IPACK) block can decrease post-operative pain in patients undergoing primary total knee arthroplasty. The main question it aims to answer is: • Is ACB/IPACK without PAI as effective as ACB/IPACK with PAI for TKA patients? Participants will be assigned to one of the following groups at random: * ACB/PACK with PAI * ACB/IPACK with saline injection Participants will also be asked to complete pre- and post-operative questionnaires.
Interventions
- DRUG Periarticular Injection (PAI)
- DRUG Saline Control Periarticular Injection (PAI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2020-12-17 |
| Est. Completion | 2022-07-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04749615
The ClinicalTrials.gov registry entry for NCT04749615 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Periarticular Injection (PAI) is the first listed.
NCT04749615 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04749615 about?
NCT04749615 is a clinical study titled "Does PAI Reduce Pain After TKA Among Knee Arthroplasty Patients Receiving ACB & IPACK?". The goal of this clinical trial is to determine whether Periarticular Injection (PAI) alongside Adductor Canal Block (ACB) and Infiltration between the Popliteal Artery and Capsule of the Knee (IPACK) block can decrease post-operative pain in patients undergoing primary total knee arthroplasty. The ...
What is the current status of trial NCT04749615?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 94 participants. The study started on 2020-12-17. Estimated completion is 2022-07-01.
What interventions are being tested in trial NCT04749615?
The interventions under investigation include: Periarticular Injection (PAI) (DRUG), Saline Control Periarticular Injection (PAI) (DRUG).
Who is sponsoring clinical trial NCT04749615?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.